Skip to Main Content

Exclusive

Latest

Exclusive Allison DeAngelis

STAT Plus: Biotech veteran John Maraganore raises $135 million for his ‘next-generation RNAi’ startup

Exclusive Megan Molteni

STAT Plus: A pariah in science, the ‘CRISPR babies’ researcher gains support from a U.S. cryptocurrency entrepreneur

Exclusive Matthew Herper

STAT Plus: Janet Woodcock, former FDA official, joins board of patient group focused on ‘rediscovering’ old drugs

Exclusive Isabella Cueto

With boost from RFK Jr. and Tucker Carlson, two chronic disease entrepreneurs vault into Trump’s orbit

Exclusive Lev Facher

To aid addiction treatment, lawmakers tell DEA to back off buprenorphine enforcement

Exclusive Lev Facher

STAT Plus: Key lawmakers pressure Biden to preserve telehealth prescribing of effective addiction treatment

Exclusive Allison DeAngelis

STAT Plus: DCVC Bio founders look for more quick returns, less overhyped AI, with new $400 million fund

Exclusive Bob Herman, J. Emory Parker, Lizzy Lawrence, Tara Bannow, and Mohana Ravindranath

STAT Plus: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion

All Coverage

Politics John Wilkerson and Rachel Cohrs Zhang

STAT Plus: Hassan indicates she’s open to tweaks on site-neutral payment reforms

Exclusive John Wilkerson and Rachel Cohrs Zhang

STAT Plus: Generic drug lobby taps former BIO exec as new CEO

advertisement

Exclusive Lizzy Lawrence

STAT Plus: FDA’s new head of device safety held senior role at company troubled by safety warnings

Exclusive John Wilkerson

STAT Plus: Cassidy seeks to exempt small biotechs from Medicare drug price negotiation

Exclusive Bob Herman

STAT Plus: Hospital giant Ascension recorded about $1.3 billion in losses from its cyberattack

Exclusive Ed Silverman and Michael Nolan

STAT Plus: Inside the quiet strategy pharma giants are using to fend off generics and drive up the cost of medicines

Exclusive John Wilkerson and Rachel Cohrs Zhang

STAT Plus: Top staffer on drug pricing to depart Senate Finance Committee

Exclusive Kate Raphael

Pediatricians’ obesity guidelines rest on shaky evidence about eating disorder risks

Exclusive Matthew Herper

STAT Plus: Former Verily executives hatch plan to invest millions in high-tech medical data

Exclusive Allison DeAngelis

STAT Plus: Novartis to spend $200 million in further bid to boost radiopharma manufacturing, market dominance

Exclusive Bob Herman

STAT Plus: Centene eliminates brokers’ commissions for Medicare drug plans

Exclusive Jason Mast

STAT Plus: Biden administration’s $3.2 billion antiviral pandemic plan is fizzling out

Exclusive Jason Mast and Allison DeAngelis

STAT Plus: Tome Biosciences, once a high-flying gene-editing startup, is floundering

Exclusive Mario Aguilar

STAT Plus: Digital therapeutics pioneer Pear’s treatments get a second life, a year after bankruptcy

Exclusive Meghana Keshavan

STAT Plus: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy

Exclusive Rachel Cohrs Zhang

STAT Plus: Former Biden White House health official joins Flagship Pioneering

Exclusive Elizabeth Cohen

STAT Plus: ‘Jerking families around’: Canceled Roche rare disease trial devastates parents, angers researchers

Exclusive Allison DeAngelis

STAT Plus: Biotech VCs are pacing for another record-low year of fundraising amid glimpses of recovery

Exclusive Adam Feuerstein

STAT Plus: Sarepta demanded Duchenne patient advocacy group censor video critical of the company

Exclusive Megan Molteni

STAT Plus: Jiankui He, creator of CRISPR-edited children, relocates to a Chinese medical tourism hub

Exclusive Timmy Broderick

STAT Plus: Key disability civil rights law will get a big refresh under Sen. Bob Casey’s new bill